0.3789
price up icon3.05%   0.0112
pre-market  시장 영업 전:  .36   -0.0189   -4.99%
loading
전일 마감가:
$0.3677
열려 있는:
$0.346
하루 거래량:
11.73M
Relative Volume:
0.61
시가총액:
$6.44M
수익:
-
순이익/손실:
$-12.89M
주가수익비율:
-0.1498
EPS:
-2.53
순현금흐름:
$-11.95M
1주 성능:
+30.16%
1개월 성능:
-41.52%
6개월 성능:
-71.72%
1년 성능:
-83.16%
1일 변동 폭
Value
$0.346
$0.45
1주일 범위
Value
$0.268
$0.661
52주 변동 폭
Value
$0.26
$2.6702

Plus Therapeutics Inc Stock (PSTV) Company Profile

Name
명칭
Plus Therapeutics Inc
Name
전화
737.255.7194
Name
주소
4200 MARATHON BLVD., AUSTIN, TX
Name
직원
21
Name
트위터
@plustxinc
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
PSTV's Discussions on Twitter

PSTV을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PSTV
Plus Therapeutics Inc
0.3789 4.95M 0 -12.89M -11.95M -2.53
Biotechnology icon
ONC
Beone Medicines Ltd Adr
251.72 25.78B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
446.48 114.53B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.3401 40.54M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.81 6.44B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
487.86 65.13B 14.09B 4.50B 2.96B 39.28

Plus Therapeutics Inc Stock (PSTV) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-17 개시 D. Boral Capital Buy
2021-01-25 개시 Ladenburg Thalmann Buy
2020-10-16 개시 Maxim Group Buy

Plus Therapeutics Inc 주식(PSTV)의 최신 뉴스

pulisher
Jun 03, 2025

Plus Therapeutics Reports Q1 2025 Financial Results - TipRanks

Jun 03, 2025
pulisher
Jun 02, 2025

Plus Therapeutics (PSTV) Reports Significant Q1 Earnings Miss - GuruFocus

Jun 02, 2025
pulisher
Jun 01, 2025

Plus Therapeutics (PSTV) Reports Q1 Loss, Misses Revenue Estimates - MSN

Jun 01, 2025
pulisher
May 31, 2025

Plus: Q1 Earnings Snapshot - New Haven Register

May 31, 2025
pulisher
May 30, 2025

Plus Therapeutics reports Q1 EPS ($1.19) vs. (75c) last year - TipRanks

May 30, 2025
pulisher
May 30, 2025

Plus Therapeutics (PSTV) Reports Financial Gains from Grant Reve - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Earnings Flash (PSTV) Plus Therapeutics Reports Q1 Loss $-1.19 Per Share, vs. FactSet Est of $-0.25 - marketscreener.com

May 30, 2025
pulisher
May 30, 2025

Plus Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 30, 2025
pulisher
May 30, 2025

Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights | PSTV Stock News - GuruFocus

May 30, 2025
pulisher
May 30, 2025

Plus Therapeutics Reports First Quarter Financial Results and Recent Business Highlights - The Manila Times

May 30, 2025
pulisher
May 30, 2025

PLUS THERAPEUTICS, INC. SEC 10-Q Report - TradingView

May 30, 2025
pulisher
May 28, 2025

Should Plus Therapeutics Inc (NASDAQ: PSTV) Investors Be Concerned? - Stocksregister

May 28, 2025
pulisher
May 27, 2025

DeFi Technologies Provides Monthly Corporate Update: Valour Reports C$1.18 Billion (US$819 Million) AUM, and Record Monthly Net Inflows of C$56 Million (US$38.8 Million) in December 2024 - The Globe and Mail

May 27, 2025
pulisher
May 25, 2025

3 No-Brainer Cloud Computing Stocks to Buy Right Now - The Globe and Mail

May 25, 2025
pulisher
May 24, 2025

Plus Therapeutics recives Nasdaq delinquency notice - MSN

May 24, 2025
pulisher
May 23, 2025

Plus Therapeutics, Inc. Receives Notification of Deficiency from - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Plus Therapeutics (PSTV) Faces Nasdaq Compliance Challenge - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Plus Therapeutics Faces Nasdaq Compliance Notice - TipRanks

May 23, 2025
pulisher
May 23, 2025

Plus Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q | PSTV Stock News - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Plus Therapeutics, Inc. Receives Notification of Deficiency - GlobeNewswire

May 23, 2025
pulisher
May 23, 2025

Plus Therapeutics Receives Nasdaq Warning: Company Has 60 Days to Submit Compliance Plan - Stock Titan

May 23, 2025
pulisher
May 23, 2025

SBAC Stock Rises 12% Year to Date: Will the Trend Continue? - The Globe and Mail

May 23, 2025
pulisher
May 19, 2025

Plus Therapeutics Receives Nasdaq Delisting Notice - TipRanks

May 19, 2025
pulisher
May 19, 2025

Corpay Stock Jumps 25% in a Year: Here's What You Should Know - The Globe and Mail

May 19, 2025
pulisher
May 17, 2025

Tesla Stock Powers Up for Fourth Straight Week of Gains - The Globe and Mail

May 17, 2025
pulisher
May 15, 2025

Plus Therapeutics Delays Quarterly Report Filing - TipRanks

May 15, 2025
pulisher
May 15, 2025

Plus Therapeutics (PSTV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - MSN

May 15, 2025
pulisher
May 14, 2025

Plus Therapeutics reports progress in CNS cancer therapy By Investing.com - Investing.com Nigeria

May 14, 2025
pulisher
May 14, 2025

Plus Therapeutics (PSTV) Showcases Promising REYOBIQ Data at Con - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Plus Therapeutics' REYOBIQ™ Shows Clinical Benefit and Safety in - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Plus Therapeutics Presents Promising ReSPECT Trial Data on REYOBIQ for Leptomeningeal Metastases at 2025 Nuclear Medicine and Neurooncology Conference - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Plus Therapeutics reports progress in CNS cancer therapy - Investing.com

May 14, 2025
pulisher
May 14, 2025

Plus Therapeutics’ REYOBIQ™ Shows Clinical Benefit and - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Plus Therapeutics’ REYOBIQ™ Shows Clinical Benefit and Safety in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases (LM) - TradingView

May 14, 2025
pulisher
May 14, 2025

Plus Therapeutics (PSTV) Showcases Promising REYOBIQ Data at Conference | PSTV Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Plus Therapeutics (PSTV) Expected to Announce Earnings on Wednesday - Defense World

May 14, 2025
pulisher
May 13, 2025

Leptomeningeal Metastases Pipeline 2025: Key Companies, MOA, - openPR.com

May 13, 2025
pulisher
May 08, 2025

Plus Therapeutics to Participate in the D. Boral Capital Inaugural Global Conference - GlobeNewswire

May 08, 2025
pulisher
May 07, 2025

Plus Therapeutics (NASDAQ:PSTV) Stock Rating Lowered by D Boral Capital - Defense World

May 07, 2025
pulisher
May 06, 2025

Plus Therapeutics (NASDAQ:PSTV) Given Hold Rating at D. Boral Capital - Defense World

May 06, 2025
pulisher
May 05, 2025

Plus Therapeutics (PSTV) Downgraded Amid Planned Reverse Stock S - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Colorectal Cancer Pipeline 2025: Latest FDA Approvals, Clinical Trials, and Emerging Therapies Assessment by DelveInsight | Novartis, Pharma Oncology, Purple Biotech Ltd, Plus Therapeutics, Processa - Barchart.com

May 05, 2025
pulisher
May 05, 2025

This Block Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga

May 05, 2025
pulisher
May 05, 2025

Plus Therapeutics (PSTV) Receives Downgrade to Hold by D. Boral Capital | PSTV Stock News - GuruFocus

May 05, 2025
pulisher
May 02, 2025

PSTV Stock Sees Decline of Approximately -22.86% in Last Five Days - knoxdaily.com

May 02, 2025
pulisher
May 02, 2025

Form 8-KCurrent report - ADVFN

May 02, 2025
pulisher
Apr 30, 2025

Plus Therapeutics Inc (PSTV) can make a big difference with a little luck - Sete News

Apr 30, 2025
pulisher
Apr 29, 2025

Investing in Plus Therapeutics Inc (PSTV): What You Must Know - knoxdaily.com

Apr 29, 2025

Plus Therapeutics Inc (PSTV) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.16
price up icon 0.87%
$31.13
price down icon 0.19%
$576.61
price down icon 1.37%
$303.77
price down icon 0.76%
$4.5807
price down icon 0.41%
$487.86
price down icon 0.60%
자본화:     |  볼륨(24시간):